Home Sleep Testing Can Replace Lab Studies for Most Sleep Apnea Patients

Obstructive sleep apnea affects tens of millions of adults and is strongly linked to cardiovascular disease, metabolic dysfunction, cognitive decline, and reduced lifespan — making accurate diagnosis a genuine longevity issue. Yet the gold-standard diagnostic tool, single-night in-laboratory polysomnography, has well-documented limitations that may be leaving many patients misclassified and untreated.

Researchers at the Medical University of Warsaw conducted a systematic review of PubMed and Scopus literature from 2015 to 2025, supplemented by landmark earlier studies and American Academy of Sleep Medicine guidelines. Their aim was to assess whether multi-night home sleep apnea testing and other ambulatory strategies could complement or replace single-night lab testing in clinical practice.

The review highlights a critical problem: the apnea-hypopnea index, the primary metric for OSA severity, varies substantially from night to night. Factors including sleep position, alcohol consumption, and sleep-stage distribution all contribute to this variability. As a result, a single lab night may misclassify a large proportion of mild-to-moderate cases — precisely the patients where treatment decisions are most uncertain.

Modern home testing devices have advanced considerably. Peripheral arterial tonometry systems, accelerometers, radar-based monitors, and under-mattress sensors now enable extended multi-night monitoring in naturalistic sleep environments. These approaches reduce the well-known 'first-night effect' seen in lab settings and can capture a more representative picture of a patient's true sleep architecture. Patients also report strong preference for home testing due to convenience and comfort.

The clinical conclusion is nuanced: for uncomplicated adults with high pre-test OSA probability, multi-night home testing is a pragmatic and evidence-supported first-line option. However, in-lab polysomnography remains the preferred standard for patients with significant comorbidities, suspected coexisting sleep disorders, or when home results are negative, inconclusive, or technically inadequate. Clinicians should match diagnostic strategy to patient complexity.